NT-pro BNP is a marker for cardiovascular dysfunction due to obstructive sleep apnea syndrome Source: Annual Congress 2010 - Nocturnal cardiology: chronic heart failure, acute chest syndrome, coronary artery disease and collagen vascular disease Year: 2010
Vasopressin, atrial natriuretic peptide and adrenomedullin as markers of hypoxic stress in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2013 –Heart, blood and metabolism in sleep disordered breathing Year: 2013
Plasma orexin-A levels in patients with obstructive sleep apnea syndrome Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea Year: 2007
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS) Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
Natriuretic peptide in sleep apnea – relation with hypoxia Source: Eur Respir J 2007; 30: Suppl. 51, 334s Year: 2007
Obstructive sleep apnoea does not cause elevated plasma levels of N-terminal pro-brain natriuretic peptide Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005
Leptin and ghrelin levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Association between obstructive sleep apnea and elevated levels of B-type natriuretic peptide in a community based sample of women Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
NT-proBNP in obstructive sleep apnoea (OSA) Source: Eur Respir J 2006; 28: Suppl. 50, 415s Year: 2006
Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
C-reactive protein levels can predict obstructive sleep apnea / hypopnea syndrome? Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
Association between obstructive sleep apnea hypopnea and metabolic syndromes Source: Eur Respir J 2004; 24: Suppl. 48, 692s Year: 2004
Relationship between adiponectin gene polymorphism and obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 412s Year: 2006
Comparison of plasma NT-proBNP level in overlap syndrome (obstructive sleep apnoea + chronic obstructive pulmonary disease) and obstructive sleep apnoea (OSA) Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep Year: 2008
Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004
Leptin in obstructive sleep apnea Source: Eur Respir J 2001; 18: Suppl. 33, 333s Year: 2001
S100B protein: A useful marker in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Catecholamine secretion in obstructive sleep apnoea (OSA) Source: Eur Respir J 2005; 26: Suppl. 49, 38s Year: 2005
C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005